To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Molecular Basis of HIV Lipodystrophy

HIV-infected patients who take highly active anti-retroviral therapy (HAART) are at high risk for metabolic complications including insulin resistance, hypertriglyceridemia, and redistribution of body fat. As yet, there is no unifying hypothesis that explains these features, although the different drugs used (protease inhibitors in particular as well as nucleoside reverse transcriptase inhibitors) have emerged as primary suspects. There may also be a role for viral factors as well. We are examining the effect of viral proteins and drugs alone and in combination on a variety of adipose tissue functions, including differentiation, lipolysis, lipogenesis, and insulin-stimulated glucose uptake, in an attempt to deconvolute this complex and troublesome aspect of antiretroviral therapy.

Contact Information

Rosen Lab
Division Of Endocrinology, Diabetes, and Metabolism
Beth Israel Deaconess Medical Center
Center for Life Sciences, 7th floor
330 Brookline Ave
Boston, MA 02215
617-735-3222
617-735-3323